Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down SyndromeKatherine A. Waugh, Joaquı́n M. Espinosa, Dmitry Baturin et al.|Cell Reports|2019Cited by 148
Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse modelKatherine A. Waugh, Joaquı́n M. Espinosa, Ross Minter et al.|Nature Genetics|2023Cited by 111
Specialized interferon action in COVID-19Matthew D. Galbraith, Joaquı́n M. Espinosa, Kohl T. Kinning et al.|Proceedings of the National Academy of Sciences|2022Cited by 94
Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibitionMatthew D. Galbraith, Joaquı́n M. Espinosa, Angela L. Rachubinski et al.|Science Advances|2023Cited by 83
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D. Galbraith, Joaquı́n M. Espinosa, Kohl T. Kinning et al.|eLife|2021Cited by 53